MedPath

Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear

Phase 2
Withdrawn
Conditions
MCL Tear
Interventions
Drug: saline
Biological: Plasma Rich in Growth Factors (PRGF)
Registration Number
NCT00743886
Lead Sponsor
Meir Medical Center
Brief Summary

To evaluate the influence of Plasma Rich in Growth Factors (PRGF) on the healing process of medial collateral ligament (MCL) tear.

Detailed Description

Autologous platelet-rich matrices may aid in the healing of ligaments \& tendons by promoting and accelerating tissue healing because of the release of growth factors including transforming growth factor (TGF)-beta1 and platelet-derived growth factor (PDGF) from platelet alpha-granules.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
50
Inclusion Criteria
  • age 18-40 years old
  • diagnosed MCL tear grade 2/3
Exclusion Criteria
  • pregnancy
  • mental or physical disabilities

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
2salinesaline
1Plasma Rich in Growth Factors (PRGF)Plasma Rich in Growth Factors (PRGF)
Primary Outcome Measures
NameTimeMethod
time and efficiency of healing1 year
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Meir Medical Center

🇮🇱

Kfar Saba, Israel

© Copyright 2025. All Rights Reserved by MedPath